Clinical Trial Update: Echothiophate Iodide for the Prevention of Progression of Myopia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating echothiophate iodide for preventing progression of myopia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• Echothiophate iodide (echothiophate iodide)

Snippet

Sponsor: Danbury Eye Physicians & Surgeons, PC | Conditions: Myopia | Phase 4 | Status: WITHDRAWN